{"id":17650,"date":"2025-09-16T11:27:54","date_gmt":"2025-09-16T09:27:54","guid":{"rendered":"https:\/\/jurmed.ro\/medici\/?p=17650"},"modified":"2025-09-16T11:34:06","modified_gmt":"2025-09-16T09:34:06","slug":"advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/","title":{"rendered":"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, anun\u021b\u0103 v\u00e2nzarea de la Advent c\u0103tre GTCR"},"content":{"rendered":"<p><a href=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-scaled.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-17652 size-medium\" src=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-300x200.jpg 300w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-1030x687.jpg 1030w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-768x512.jpg 768w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-1536x1024.jpg 1536w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-2048x1365.jpg 2048w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-150x100.jpg 150w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-696x464.jpg 696w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-1068x712.jpg 1068w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2025\/09\/Zentiva-1920x1280.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><a href=\"https:\/\/jurmed.ro\/medici\/zentiva-romania-initiaza-actiuni-legale-contestand-directiva-privind-tratarea-apelor-urbane-reziduale-pentru-a-proteja-accesul-la-servicii-medicale-accesibile-pentru-milioane-de-oameni-din-europa\/\">Zentiva<\/a>, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR \u2013 doi investitori globali de capital privat de prim rang \u2013 anun\u021b\u0103 ast\u0103zi v\u00e2nzarea grupului Zentiva de la Advent c\u0103tre GTCR.<\/p>\n<p>De la achizi\u021bia Zentiva de la Sanofi, \u00een 2018, Advent a colaborat \u00eendeaproape cu echipa de management pentru a transforma cu succes compania, investind \u00een extinderea portofoliului de medicamente \u0219i a capacit\u0103\u021bilor de produc\u021bie ale Zentiva, at\u00e2t pe cale organic\u0103, c\u00e2t \u0219i prin fuziuni \u0219i achizi\u021bii direc\u021bionate. Acest program de transformare a consolidat Zentiva ca o afacere independent\u0103 de mare succes, cu un accent puternic pe excelen\u021ba opera\u021bional\u0103 \u0219i pe capacit\u0103\u021bile de cercetare \u0219i dezvoltare, deservind milioane de pacien\u021bi din \u00eentreaga Europ\u0103.<\/p>\n<p>GTCR este o firm\u0103 de capital privat de top, cu o lung\u0103 istorie de investi\u021bii \u00een sectorul s\u0103n\u0103t\u0103\u021bii \u0219i o expertiz\u0103 profund\u0103 \u00een industria farmaceutic\u0103, investind \u00een mai multe platforme de referin\u021b\u0103 \u0219i realiz\u00e2nd zeci de achizi\u021bii \u00een acest domeniu \u00een ultimii 20 de ani. Cu experien\u021ba sa dovedit\u0103 \u00een industria farmaceutic\u0103 \u0219i accentul pus pe parteneriatul cu echipele de management pentru a construi companii de top prin cre\u0219tere organic\u0103, inova\u021bie de produs \u0219i achizi\u021bii strategice, GTCR este bine pozi\u021bionat\u0103 pentru a sprijini Zentiva \u00een urm\u0103toarea etap\u0103 de dezvoltare.<\/p>\n<p><strong>Steffen Saltofte, CEO, Zentiva, a declarat: <\/strong><\/p>\n<p>\u201eAdvent a fost un partener excep\u021bional \u00een parcursul de transformare al Zentiva. Angajamentul lor de a investi \u00een capabilit\u0103\u021bile noastre, \u00een portofoliul de produse \u0219i \u00een baza de produc\u021bie a fost esen\u021bial pentru cre\u0219terea noastr\u0103 \u0219i pentru a ne asigura c\u0103 putem deservi mai bine milioane de pacien\u021bi din \u00eentreaga Europ\u0103. Pe m\u0103sur\u0103 ce mergem mai departe cu GTCR, suntem \u00eenc\u00e2nta\u021bi s\u0103 construim pe acest impuls, pentru a asigura o cre\u0219tere continu\u0103 \u0219i pentru a extinde accesul la medicamente de \u00eenalt\u0103 calitate \u0219i la pre\u021buri accesibile.\u201d<\/p>\n<p><strong>Tom Allen, Managing Director la Advent, a declarat: <\/strong><\/p>\n<p>\u201eC\u00e2nd am achizi\u021bionat Zentiva de la Sanofi, \u00een 2018, am v\u0103zut oportunitatea de a construi un lider european independent \u00een domeniul medicamentelor accesibile. Printr-o colaborare activ\u0103 cu echipa de management \u0219i prin investi\u021bii \u00een capabilit\u0103\u021bile companiei, Zentiva \u0219i-a dublat veniturile \u0219i EBITDA, stabilind o funda\u021bie solid\u0103 pentru viitor. Zentiva exemplific\u0103 abilitatea Advent de a desprinde \u0219i transforma divizii non-core \u00een afaceri de succes \u0219i lideri de pia\u021b\u0103. Suntem m\u00e2ndri de ceea ce am realizat \u0219i avem \u00eencredere c\u0103 Zentiva va continua s\u0103 prospere sub proprietatea GTCR.\u201d<\/p>\n<p><strong>Sean Cunningham, Managing Director \u0219i Head of Healthcare la GTCR, a declarat: <\/strong><\/p>\n<p>\u201eSuntem \u00eenc\u00e2nta\u021bi s\u0103 colabor\u0103m cu Steffen Saltofte \u0219i talentata echip\u0103 de management Zentiva pentru urm\u0103toarea etap\u0103 de cre\u0219tere. Compania are un istoric impresionant de expansiune organic\u0103 \u0219i anorganic\u0103, un portofoliu solid \u00een dezvoltare \u0219i o platform\u0103 de produc\u021bie extrem de eficient\u0103, cu un accent esen\u021bial pe livrarea de medicamente de valoare pacien\u021bilor din \u00eentreaga Europ\u0103. A\u0219tept\u0103m cu ner\u0103bdare s\u0103 sprijinim Zentiva \u00een continuarea misiunii sale.\u201d<\/p>\n<p>Tranzac\u021bia este supus\u0103 aprob\u0103rilor de reglementare uzuale, iar \u00eenchiderea acesteia este a\u0219teptat\u0103 la \u00eenceputul anului 2026.<\/p>\n<p>Advent a fost consiliat de Goldman Sachs \u0219i PJT Partners ca principali consultan\u021bi financiari \u0219i de Freshfields ca principal consultant juridic.<\/p>\n<p>GTCR a fost consiliat de Barclays Bank PLC, prin Investment Bank, \u0219i BNP Paribas ca principali consultan\u021bi financiari, Morgan Stanley &amp; Co. LLC ca consultant financiar \u0219i Kirkland &amp; Ellis LLP ca consultant juridic.<\/p>\n<p>Despre Zentiva<\/p>\n<p>Zentiva ofer\u0103 s\u0103n\u0103tate \u0219i stare de bine pentru toate genera\u021biile, concentr\u00e2ndu-se pe dezvoltarea, producerea \u0219i furnizarea de medicamente de \u00eenalt\u0103 calitate \u0219i la pre\u021buri accesibile pentru peste 100 de milioane de oameni din peste 30 de \u021b\u0103ri din Europa \u0219i nu numai. Zentiva de\u021bine patru fabrici proprii \u0219i o re\u021bea extins\u0103 de parteneri de produc\u021bie externi pentru a asigura securitatea aprovizion\u0103rii. Zentiva are peste 5.000 de angaja\u021bi, uni\u021bi prin angajamentul fa\u021b\u0103 de oamenii care depind de medicamentele noastre zi de zi. Viziteaz\u0103-ne pe www.zentiva.com<\/p>\n<p>Despre Advent<\/p>\n<p>Advent este un investitor global de capital privat de top, dedicat colabor\u0103rii cu echipe de management, antreprenori \u0219i fondatori pentru a transforma afaceri. Cu 16 birouri pe cinci continente, administr\u0103m active \u00een valoare de peste 100 miliarde USD* \u0219i am realizat 435 de investi\u021bii \u00een 44 de \u021b\u0103ri.<\/p>\n<p>De la \u00eenfiin\u021barea noastr\u0103, \u00een 1984, am dezvoltat o expertiz\u0103 de pia\u021b\u0103 specializat\u0103 \u00een cinci sectoare principale: servicii de afaceri \u0219i financiare, consum, s\u0103n\u0103tate, industrie \u0219i tehnologie. Aceast\u0103 abordare este consolidat\u0103 de cuno\u0219tin\u021bele aprofundate pe sub-sectoare, care ghideaz\u0103 fiecare aspect al strategiei noastre de investi\u021bii, de la identificarea oportunit\u0103\u021bilor p\u00e2n\u0103 la implementarea planurilor de creare de valoare. Aducem expertiz\u0103 opera\u021bional\u0103 practic\u0103 pentru a accelera \u0219i \u00eembun\u0103t\u0103\u021bi afacerile.<\/p>\n<p>Fiind unul dintre cele mai mari parteneriate private, cei peste 675 de colegi ai no\u0219tri valorific\u0103 \u00eentregul ecosistem de resurse globale ale Advent, inclusiv Grupul de Suport al Portofoliului, cuno\u0219tin\u021bele oferite de parteneri opera\u021bionali \u0219i consultan\u021bi, precum \u0219i instrumente personalizate pentru a sprijini \u0219i ghida companiile din portofoliu \u00een atingerea obiectivelor strategice.<\/p>\n<p>*Activele administrate (AUM) la 30 iunie 2025. AUM include active apar\u021bin\u00e2nd clien\u021bilor Advent, precum \u0219i vehicule de co-investi\u021bii ale angaja\u021bilor \u0219i ter\u021bilor. Pentru mai multe informa\u021bii accesa\u021bi website sau LinkedIn.<\/p>\n<p>Despre GTCR Fondat\u0103 \u00een 1980, GTCR este o firm\u0103 de capital privat de top care investe\u0219te urm\u00e2nd The Leaders Strategy\u2122 \u2013 identific\u00e2nd \u0219i colabor\u00e2nd cu lideri de management din domenii cheie pentru a descoperi, achizi\u021biona \u0219i construi companii de top prin cre\u0219tere organic\u0103 \u0219i achizi\u021bii strategice. GTCR se concentreaz\u0103 pe investi\u021bii \u00een cre\u0219tere transformatoare \u00een companii din sectoarele: servicii de afaceri \u0219i consum, servicii financiare \u0219i tehnologie, s\u0103n\u0103tate \u0219i tehnologie, media &amp; telecomunica\u021bii. De la \u00eenfiin\u021bare, GTCR a investit peste 30 miliarde USD \u00een peste 290 de companii, iar \u00een prezent administreaz\u0103 aproximativ 50 miliarde USD \u00een capital propriu. GTCR are sediul \u00een Chicago \u0219i birouri \u00een New York \u0219i West Palm Beach. Pentru mai multe informa\u021bii, vizita\u021bi <span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"https:\/\/www.gtcr.com\/\">www.gtcr.com<\/a><\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"188\"><strong>Contacte media <\/strong>Peter Folland<\/td>\n<td width=\"188\">Marie-Claire Rees<\/td>\n<td width=\"188\">Joshua Clarkson<\/td>\n<\/tr>\n<tr>\n<td width=\"188\">Vice President, Communications, Advent<\/td>\n<td width=\"188\">Head of Communications, Zentiva<\/td>\n<td width=\"188\">Managing Director, Prosek Partners<\/td>\n<\/tr>\n<tr>\n<td width=\"188\"><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"mailto:pfolland@adventinternational.co.uk\">pfolland@adventinternational.co.uk<\/a><\/span><\/td>\n<td width=\"188\"><span style=\"background-color: #ffffff; color: #0000ff;\">marie-claire.rees@zentiva.com<\/span><\/td>\n<td width=\"188\"><span style=\"color: #0000ff;\">pro-GTCR@prosek.com<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR \u2013 doi investitori globali de capital privat de prim rang \u2013 anun\u021b\u0103 ast\u0103zi v\u00e2nzarea [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":14435,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[1241,1243,1042,1242,586],"class_list":["post-17650","post","type-post","status-publish","format-standard","has-post-thumbnail","category-stiri-noutati","tag-advent","tag-gtcr","tag-steffen-saltofte","tag-tom-allen","tag-zentiva"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Advent este un investitor global de capital privat de top<\/title>\n<meta name=\"description\" content=\"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advent este un investitor global de capital privat de top\" \/>\n<meta property=\"og:description\" content=\"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Medici\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-16T09:27:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-16T09:34:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"442\" \/>\n\t<meta property=\"og:image:height\" content=\"202\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"costelv\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"costelv\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/\"},\"author\":{\"name\":\"costelv\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d\"},\"headline\":\"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, anun\u021b\u0103 v\u00e2nzarea de la Advent c\u0103tre GTCR\",\"datePublished\":\"2025-09-16T09:27:54+00:00\",\"dateModified\":\"2025-09-16T09:34:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/\"},\"wordCount\":1093,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png\",\"keywords\":[\"Advent\",\"GTCR\",\"Steffen Saltofte\",\"Tom Allen\",\"Zentiva\"],\"articleSection\":[\"Stiri \/ Noutati\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/\",\"url\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/\",\"name\":\"Advent este un investitor global de capital privat de top\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png\",\"datePublished\":\"2025-09-16T09:27:54+00:00\",\"dateModified\":\"2025-09-16T09:34:06+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d\"},\"description\":\"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png\",\"contentUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png\",\"width\":442,\"height\":202,\"caption\":\"Advent\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/medici\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, anun\u021b\u0103 v\u00e2nzarea de la Advent c\u0103tre GTCR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\",\"url\":\"https:\/\/jurmed.ro\/medici\/\",\"name\":\"Jurmed - Medici\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/medici\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d\",\"name\":\"costelv\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g\",\"caption\":\"costelv\"},\"url\":\"https:\/\/jurmed.ro\/medici\/author\/costelvoicu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advent este un investitor global de capital privat de top","description":"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/","og_locale":"ro_RO","og_type":"article","og_title":"Advent este un investitor global de capital privat de top","og_description":"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR","og_url":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/","og_site_name":"Jurmed - Medici","article_published_time":"2025-09-16T09:27:54+00:00","article_modified_time":"2025-09-16T09:34:06+00:00","og_image":[{"width":442,"height":202,"url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png","type":"image\/png"}],"author":"costelv","twitter_misc":{"Scris de":"costelv","Timp estimat pentru citire":"6 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/"},"author":{"name":"costelv","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d"},"headline":"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, anun\u021b\u0103 v\u00e2nzarea de la Advent c\u0103tre GTCR","datePublished":"2025-09-16T09:27:54+00:00","dateModified":"2025-09-16T09:34:06+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/"},"wordCount":1093,"commentCount":0,"image":{"@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png","keywords":["Advent","GTCR","Steffen Saltofte","Tom Allen","Zentiva"],"articleSection":["Stiri \/ Noutati"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/","url":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/","name":"Advent este un investitor global de capital privat de top","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png","datePublished":"2025-09-16T09:27:54+00:00","dateModified":"2025-09-16T09:34:06+00:00","author":{"@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d"},"description":"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, \u00eempreun\u0103 cu Advent \u0219i GTCR","breadcrumb":{"@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#primaryimage","url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png","contentUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2023\/01\/zentiva-1.png","width":442,"height":202,"caption":"Advent"},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/medici\/advent-a-fost-un-partener-exceptional-in-parcursul-de-transformare-al-zentiva\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/medici\/"},{"@type":"ListItem","position":2,"name":"Zentiva, o companie farmaceutic\u0103 european\u0103 de top specializat\u0103 \u00een medicamente generice, anun\u021b\u0103 v\u00e2nzarea de la Advent c\u0103tre GTCR"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/medici\/#website","url":"https:\/\/jurmed.ro\/medici\/","name":"Jurmed - Medici","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/medici\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d","name":"costelv","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g","caption":"costelv"},"url":"https:\/\/jurmed.ro\/medici\/author\/costelvoicu\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/17650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/comments?post=17650"}],"version-history":[{"count":4,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/17650\/revisions"}],"predecessor-version":[{"id":17655,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/17650\/revisions\/17655"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media\/14435"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media?parent=17650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/categories?post=17650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tags?post=17650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}